OpenAI acquires Orchestra Bio
OpenAI · 21 Oct 2026, 06:35 AEST
OpenAI has acquired the biotech startup Orchestra Bio to enhance its life sciences research capabilities. The acquisition will integrate Orchestra's technology into OpenAI's Rosalind model and related tools for researchers.
Key facts
- OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
- OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website.
- Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC.
- Orchestra creates AI agents that help biotech companies manage the minutiae of drug discovery operations, from tracking finances to resolving scheduling issues with clinical trials.
Read aloud
Open A I has acquired the biotech startup Orchestra Bio to enhance its life sciences research capabilities. The acquisition will integrate Orchestra's technology into Open A I's Rosalind model and related tools for researchers. Open A I says it's adding Orchestra's team and technology to work on Rosalind, its A I model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results. Open A I on Tuesday acquired a four-year-old A I biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around twenty dollars million as of twenty twenty five from backers like Andreessen Horowitz, Atria, and 8VC. Orchestra creates A I agents that help biotech companies manage the minutiae of drug discovery operations, from tracking finances to resolving scheduling issues with clinical trials.
Sources in this cluster
- OpenAI acquires Orchestra Bio
OpenAI · 20 Oct 2026, 10:00 AEST
- OpenAI acquires startup Orchestra Bio to beef up its biotech business
TechCrunch AI · 21 Oct 2026, 06:35 AEST